Rights and permissions
About this article
Cite this article
Novartis breaches code, misleading drug advertising continues. Pharmacoecon. Outcomes News 394, 11 (2003). https://doi.org/10.1007/BF03275719
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03275719